Key Points
-
Spinal muscular atrophy (SMA) is caused by reduced amounts of the ubiquitously expressed survival motor neuron protein (SMN). SMN functions in RNA metabolism, but the question of which aspect of its function is disrupted to give a motor neuron disease remains unanswered.
-
SMN functions in the assembly of Sm proteins onto small nuclear RNAs (snRNAs) during pre-mRNA splicing. It has been suggested that SMN might have a role in the assembly of other ribonucleoprotein (RNP) complexes.
-
SMA is caused by loss or mutation of SMN1 and retention of SMN2,leading to low SMN levels. Proteins that carry mild missense mutations complement SMN2 to restore assembly activity and give a mild phenotype.
-
Loss of SMN in all species results in lethality, indicating that SMN has an essential function. Animal models of SMA can be created by reducing the levels of SMN.
-
It has been proposed that reduction of SMN levels results in an alteration of the small nuclear ribonucleoprotein (snRNP) profile. This is supported by the correlation between snRNP assembly activity and SMA severity in mice; however, a clear indication of the downstream target genes that are affected is currently lacking.
-
SMN is found in axons of cultured cells, and a second hypothesis suggests that altered mRNA transport in axons may contribute to SMA. However, a clear indication of what SMN function is disrupted to alter mRNA transport is lacking.
-
SMN functions in the assembly of RNPs, but it remains unresolved whether it is an axonal or an snRNP component that is disrupted in SMA. Experiments showing a clear suppression of the phenotype by manipulating a particular pathway could be used to demonstrate the crucial pathway in SMA.
Abstract
Many neurogenetic disorders are caused by the mutation of ubiquitously expressed genes. One such disorder, spinal muscular atrophy, is caused by loss or mutation of the survival motor neuron1 gene (SMN1), leading to reduced SMN protein levels and a selective dysfunction of motor neurons. SMN, together with partner proteins, functions in the assembly of small nuclear ribonucleoproteins (snRNPs), which are important for pre-mRNA splicing. It has also been suggested that SMN might function in the assembly of other ribonucleoprotein complexes. Two hypotheses have been proposed to explain the molecular dysfunction that gives rise to spinal muscular atrophy (SMA) and its specificity to a particular group of neurons. The first hypothesis states that the loss of SMN's well-known function in snRNP assembly causes an alteration in the splicing of a specific gene (or genes). The second hypothesis proposes that SMN is crucial for the transport of mRNA in neurons and that disruption of this function results in SMA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
£119.00 per year
only £9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Crawford, T. O. & Pardo, C. A. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3, 97–110 (1996).
Roberts, D. F., Chavez, J. & Court, S. D. The genetic component in child mortality. Arch. Dis. Child. 45, 33–38 (1970).
Pearn, J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med. Genet. 15, 409–413 (1978).
Melki, J. Spinal muscular atrophy. Curr. Opin. Neurol. 10, 381–385 (1997).
McAndrew, P. E. et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am. J. Hum. Genet. 60, 1411–1422 (1997). The first analysis of SMN1 and SMN2 copy number and a clear indication that copy number of SMN2 modifies SMA phenotype.
Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155–165 (1995). The identification of an SMN gene as causative in SMA, and a discussion of the similarity of SMN1 and SMN2 .
Pasinelli, P. & Brown, R. H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Rev. Neurosci. 7, 710–723 (2006).
Walling, H. W., Baldassare, J. J. & Westfall, T. C. Molecular aspects of Huntington's disease. J. Neurosci. Res. 54, 301–308 (1998).
Park, S. G., Schimmel, P. & Kim, S. Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl Acad. Sci. USA 105, 11043–11049 (2008).
Salinas, S., Carazo-Salas, R. E., Proukakis, C., Schiavo, G. & Warner, T. T. Spastin and microtubules: functions in health and disease. J. Neurosci. Res. 85, 2778–2782 (2007).
Fink, J. K. & Rainier, S. Hereditary spastic paraplegia: spastin phenotype and function. Arch. Neurol. 61, 830–833 (2004).
Thomas, B. & Beal, M. F. Parkinson's disease. Hum. Mol. Genet. 16, R183–R194 (2007).
Liu, Q. & Dreyfuss, G. A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15, 3555–3565 (1996).
Young, P. J. et al. Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN. Exp. Cell Res. 265, 252–261 (2001).
Young, P. J., Le, T. T., thi Man, N., Burghes, A. H. & Morris, G. E. The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. Exp. Cell Res. 256, 365–374 (2000).
Carvalho, T. et al. The spinal muscular atrophy disease gene product, SMN: a link between snRNP biogenesis and the Cajal (coiled) body. J. Cell Biol. 147, 715–728 (1999).
Matera, A. G. & Frey, M. R. Coiled bodies and gems: Janus or gemini? Am. J. Hum. Genet. 63, 317–321 (1998).
Setola, V. et al. Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis. Proc. Natl Acad. Sci. USA 104, 1959–1964 (2007).
Burghes, H. M. Other forms of survival motor neuron protein and spinal muscular atrophy: an opinion. Neuromuscul. Disord. 18, 82–83 (2008).
Eggert, C., Chari, A., Laggerbauer, B. & Fischer, U. Spinal muscular atrophy: the RNP connection. Trends Mol. Med. 12, 113–121 (2006).
Simic, G. Pathogenesis of proximal autosomal recessive spinal muscular atrophy. Acta Neuropathol. 116, 223–234 (2008).
Meister, G., Eggert, C. & Fischer, U. SMN-mediated assembly of RNPs: a complex story. Trends Cell Biol. 12, 472–478 (2002).
Paushkin, S., Gubitz, A. K., Massenet, S. & Dreyfuss, G. The SMN complex, an assemblyosome of ribonucleoproteins. Curr. Opin. Cell Biol. 14, 305–312 (2002).
Hao le, T. et al. Absence of gemin5 from SMN complexes in nuclear Cajal bodies. BMC Cell Biol. 8, 28 (2007).
Pellizzoni, L. Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep. 8, 340–345 (2007).
Gubitz, A. K., Feng, W. & Dreyfuss, G. The SMN complex. Exp. Cell Res. 296, 51–56 (2004).
Pellizzoni, L., Yong, J. & Dreyfuss, G. Essential role for the SMN complex in the specificity of snRNP assembly. Science 298, 1775–1779 (2002).
Meister, G., Buhler, D., Pillai, R., Lottspeich, F. & Fischer, U. A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs. Nature Cell Biol. 3, 945–949 (2001).
Fischer, U., Liu, Q. & Dreyfuss, G. The SMN–SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90, 1023–1029 (1997).
Liu, Q., Fischer, U., Wang, F. & Dreyfuss, G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90, 1013–1021 (1997). References 27–30 provided a clear demonstration that SMN functions to assemble Sm proteins onto snRNA.
Ogawa, C. et al. Role of survival motor neuron complex components in small nuclear ribonucleoprotein assembly. J. Biol. Chem. 284, 14609–14617 (2009).
Raker, V. A., Hartmuth, K., Kastner, B. & Luhrmann, R. Spliceosomal U snRNP core assembly: Sm proteins assemble onto an Sm site RNA nonanucleotide in a specific and thermodynamically stable manner. Mol. Cell. Biol. 19, 6554–6565 (1999).
Meister, G. et al. Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins. Hum. Mol. Genet. 9, 1977–1986 (2000).
Otter, S. et al. A comprehensive interaction map of the human survival of motor neuron (SMN) complex. J. Biol. Chem. 282, 5825–5833 (2007).
Carissimi, C., Saieva, L., Gabanella, F. & Pellizzoni, L. Gemin8 is required for the architecture and function of the survival motor neuron complex. J. Biol. Chem. 281, 37009–37016 (2006).
Lorson, C. L. et al. SMN oligomerization defect correlates with spinal muscular atrophy severity. Nature Genet. 19, 63–66 (1998). Demonstrated that missense mutations in SMN affect the ability of SMN to oligomerize with itself.
Pellizzoni, L., Charroux, B. & Dreyfuss, G. SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc. Natl Acad. Sci. USA 96, 11167–11172 (1999). Demonstrated that SMN needs to be oligomeric to efficiently bind Sm proteins.
Zhang, H. L. et al. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J. Neurosci. 23, 6627–6637 (2003).
Le, T. T. et al. SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14, 845–857 (2005).
Workman, E. et al. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice. Hum. Mol. Genet. 18, 2215–2229 (2009). A clear indication of mild SMN missense mutation alleles complementing SMN2.
Pu, W. T., Krapivinsky, G. B., Krapivinsky, L. & Clapham, D. E. pICln inhibits snRNP biogenesis by binding core spliceosomal proteins. Mol. Cell. Biol. 19, 4113–4120 (1999).
Meister, G. et al. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr. Biol. 11, 1990–1994 (2001).
Friesen, W. J. et al. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol. Cell. Biol. 21, 8289–300 (2001).
Chari, A. et al. An assembly chaperone collaborates with the SMN complex to generate spliceosomal snRNPs. Cell 135, 497–509 (2008).
Meister, G. & Fischer, U. Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPS. EMBO J. 21, 5853–5863 (2002).
Battle, D. J. et al. The Gemin5 protein of the SMN complex identifies snRNAs. Mol. Cell 23, 273–279 (2006).
Shpargel, K. B. & Matera, A. G. Gemin proteins are required for efficient assembly of Sm-class ribonucleoproteins. Proc. Natl Acad. Sci. USA 102, 17372–17377 (2005). The first assay of the ability of a panel of SMN missense alleles to perform snRNP assembly.
Friesen, W. J. & Dreyfuss, G. Specific sequences of the Sm and Sm-like (LSm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN). J. Biol. Chem. 275, 26370–26375 (2000).
Brahms, H., Meheus, L., de Brabandere, V., Fischer, U. & Luhrmann, R. Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 7, 1531–1542 (2001).
Narayanan, U., Ospina, J. K., Frey, M. R., Hebert, M. D. & Matera, A. G. SMN, the spinal muscular atrophy protein, forms a pre-import snRNP complex with snurportin1 and importin β. Hum. Mol. Genet. 11, 1785–1795 (2002).
Terns, M. P. & Terns, R. M. Macromolecular complexes: SMN--the master assembler. Curr. Biol. 11, R862–R864 (2001).
Khusial, P., Plaag, R. & Zieve, G. W. LSm proteins form heptameric rings that bind to RNA via repeating motifs. Trends Biochem. Sci. 30, 522–528 (2005).
He, W. & Parker, R. Functions of LSm proteins in mRNA degradation and splicing. Curr. Opin. Cell Biol. 12, 346–350 (2000).
Kiss, T. Biogenesis of small nuclear RNPs. J. Cell Sci. 117, 5949–5951 (2004).
Pillai, R. S. et al. Unique Sm core structure of U7 snRNPs: assembly by a specialized SMN complex and the role of a new component, LSm11, in histone RNA processing. Genes Dev. 17, 2321–2333 (2003).
Zhang, Z. et al. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133, 585–600 (2008). With reference 104, this work demonstrated that a reduced SMN level, which occurs in SMA, leads to reduced assembly of snRNPs, in turn reducing the steady-state level of certain snRNPs, which may selectively alter splicing.
Tharun, S., Muhlrad, D., Chowdhury, A. & Parker, R. Mutations in the Saccharomyces cerevisiae Lsm1 gene that affect mRNA decapping and 3′ end protection. Genetics 170, 33–46 (2005).
Bergman, N. et al. LSm proteins bind and stabilize RNAs containing 5′ poly(A) tracts. Nature Struct. Mol. Biol. 14, 824–831 (2007).
di Penta, A. et al. Dendritic LSm1/CBP80-mRNPs mark the early steps of transport commitment and translational control. J. Cell Biol. 184, 423–435 (2009).
Gandini, R. et al. LSm4 associates with the plasma membrane and acts as a co-factor in cell volume regulation. Cell Physiol. Biochem. 22, 579–590 (2008).
Decker, C. J. & Parker, R. car-1 and trailer hitch: driving mRNP granule function at the ER? J. Cell Biol. 173, 159–163 (2006).
Brody, T. The interactive fly: gene networks, development and the internet. Trends Genet. 15, 333–334 (1999).
Tanaka, K. J. et al. RAP55, a cytoplasmic mRNP component, represses translation in Xenopus oocytes. J. Biol. Chem. 281, 40096–40106 (2006).
Yang, W. H., Yu, J. H., Gulick, T., Bloch, K. D. & Bloch, D. B. RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA 12, 547–554 (2006).
Tritschler, F. et al. Similar modes of interaction enable Trailer hitch and EDC3 to associate with DCP1 and Me31B in distinct protein complexes. Mol. Cell. Biol. 28, 6695–6708 (2008).
Rossoll, W. et al. Specific interaction of SMN, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for SMN in RNA processing in motor axons? Hum. Mol. Genet. 11, 93–105 (2002). With reference 124, this work demonstrated the presence of SMN in axons.
Rossoll, W. et al. SMN, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons. J. Cell Biol. 163, 801–812 (2003). In this work, cultured motor neurons from SMA mice showed altered axon length and altered transport of β-actin mRNA to axon tips.
Zhang, H. et al. Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J. Neurosci. 26, 8622–8632 (2006).
Gu, W., Pan, F., Zhang, H., Bassell, G. J. & Singer, R. H. A predominantly nuclear protein affecting cytoplasmic localization of β-actin mRNA in fibroblasts and neurons. J. Cell Biol. 156, 41–51 (2002).
Cheng, D., Cote, J., Shaaban, S. & Bedford, M. T. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol. Cell 25, 71–83 (2007).
Claus, P., Bruns, A. F. & Grothe, C. Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem. J. 384, 559–565 (2004).
Piazzon, N. et al. In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein. J. Biol. Chem. 283, 5598–5610 (2008).
Mourelatos, Z., Abel, L., Yong, J., Kataoka, N. & Dreyfuss, G. SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 20, 5443–5452 (2001).
Sharma, A. et al. A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells. Exp. Cell Res. 309, 185–197 (2005).
Pellizzoni, L., Charroux, B., Rappsilber, J., Mann, M. & Dreyfuss, G. A functional interaction between the survival motor neuron complex and RNA polymerase II. J. Cell Biol. 152, 75–85 (2001).
Jones, K. W. et al. Direct interaction of the spinal muscular atrophy disease protein SMN with the small nucleolar RNA-associated protein fibrillarin. J. Biol. Chem. 276, 38645–38651 (2001).
Watkins, N. J. et al. Assembly and maturation of the U3 snoRNP in the nucleoplasm in a large dynamic multiprotein complex. Mol. Cell 16, 789–798 (2004).
Matera, A. G., Terns, R. M. & Terns, M. P. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nature Rev. Mol. Cell Biol. 8, 209–220 (2007).
Burghes, A. H. When is a deletion not a deletion? When it is converted. Am. J. Hum. Genet. 61, 9–15 (1997).
Schrank, B. et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA 94, 9920–9925 (1997). The first demonstration that loss of SMN in mammals is an embryonic lethal phenotype, which showed that SMN is an essential gene.
Zerres, K. & Rudnik-Schoneborn, S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch. Neurol. 52, 518–523 (1995).
Feldkotter, M., Schwarzer, V., Wirth, R., Wienker, T. F. & Wirth, B. Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet. 70, 358–368 (2002).
Mailman, M. D. et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet. Med. 4, 20–26 (2002).
Monani, U. R. et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177–1183 (1999). With reference 89, this work showed that the essential difference between SMN1 and SMN2 is the single-nucleotide change in exon 7 that alters splicing.
Monani, U. R., McPherson, J. D. & Burghes, A. H. Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). Biochim. Biophys. Acta 1445, 330–336 (1999).
Echaniz-Laguna, A., Miniou, P., Bartholdi, D. & Melki, J. The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. Am. J. Hum. Genet. 64, 1365–1370 (1999).
Lefebvre, S. et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genet. 16, 265–269 (1997). This work and reference 88 showed the correlation of SMN level with the severity of SMA. In reference 87 it was also shown that the SMNY272C mutation resulted in reduced SMN levels in SMA.
Coovert, D. D. et al. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205–1014 (1997).
Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307–6311 (1999).
Cartegni, L. & Krainer, A. R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nature Genet. 30, 377–384 (2002).
Kashima, T. & Manley, J. L. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nature Genet. 34, 460–463 (2003).
Gennarelli, M. et al. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem. Biophys. Res. Commun. 213, 342–348 (1995).
Lorson, C. L. & Androphy, E. J. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 9, 259–265 (2000).
Burnett, B. G. et al. Regulation of SMN protein stability. Mol. Cell. Biol. 29, 1107–1115 (2009).
Alias, L. et al. Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum. Genet. 125, 29–39 (2009).
Sun, Y. et al. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy. Hum. Mutat. 25, 64–71 (2005).
Buhler, D., Raker, V., Luhrmann, R. & Fischer, U. Essential role for the Tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum. Mol. Genet. 8, 2351–2357 (1999).
Monani, U. R. et al. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J. Cell Biol. 160, 41–52 (2003).
Ogawa, C. et al. Gemin2 plays an important role in stabilizing the survival of motor neuron complex. J. Biol. Chem. 282, 11122–11134 (2007).
Kotani, T. et al. A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins. J. Neurol. 254, 624–630 (2007).
Clermont, O. et al. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations. Hum. Mutat. 24, 417–427 (2004).
Cusco, I., Barcelo, M. J., del Rio, E., Baiget, M. & Tizzano, E. F. Detection of novel mutations in the SMN Tudor domain in type I SMA patients. Neurology 63, 146–149 (2004).
Parsons, D. W. et al. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am. J. Hum. Genet. 63, 1712–1723 (1998).
Gabanella, F. et al. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS ONE 2, e921 (2007).
Owen, N., Doe, C. L., Mellor, J. & Davies, K. E. Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein. Hum. Mol. Genet. 9, 675–684 (2000).
Paushkin, S. et al. The survival motor neuron protein of Schizosacharomyces pombe. Conservation of survival motor neuron interaction domains in divergent organisms. J. Biol. Chem. 275, 23841–23846 (2000).
Hsieh-Li, H. M. et al. A mouse model for spinal muscular atrophy. Nature Genet. 24, 66–70 (2000).
Monani, U. R. et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn−/− mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333–339 (2000). References 107 and 108 produced the first animal model of SMA that recapitulated the situation in SMA patients — loss of SMN1 and retention of SMN2.
McGovern, V. L., Gavrilina, T. O., Beattie, C. E. & Burghes, A. H. Embryonic motor axon development in the severe SMA mouse. Hum. Mol. Genet. 17, 2900–2909 (2008).
Miguel-Aliaga, I. et al. The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability. Hum. Mol. Genet. 8, 2133–2143 (1999).
Chan, Y. B. et al. Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum. Mol. Genet. 12, 1367–1376 (2003).
Miguel-Aliaga, I., Chan, Y. B., Davies, K. E. & van den Heuvel, M. Disruption of SMN function by ectopic expression of the human SMN gene in Drosophila. FEBS Lett. 486, 99–102 (2000).
McWhorter, M. L., Monani, U. R., Burghes, A. H. & Beattie, C. E. Knockdown of the survival motor neuron (SMN) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919–932 (2003). Demonstrated that knockdown of SMN in zebrafish causes a cell-autonomous defect in motor axons that can be corrected with SMN expression, allowing the crucial pathways in SMA to be assayed.
Frugier, T. et al. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 9, 849–858 (2000).
Hannus, S., Buhler, D., Romano, M., Seraphin, B. & Fischer, U. The Schizosaccharomyces pombe protein Yab8p and a novel factor, Yip1p, share structural and functional similarity with the spinal muscular atrophy-associated proteins SMN and SIP1. Hum. Mol. Genet. 9, 663–674 (2000).
Briese, M. et al. Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Hum. Mol. Genet. 18, 97–104 (2009).
Cifuentes-Diaz, C. et al. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J. Cell Biol. 152, 1107–1114 (2001).
Vitte, J. M. et al. Deletion of murine SMN exon 7 directed to liver leads to severe defect of liver development associated with iron overload. Am. J. Pathol. 165, 1731–1741 (2004).
Gavrilina, T. O. et al. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum. Mol. Genet. 17, 1063–1075 (2008). This work showed that the presence of two copies of SMN2 produces sufficient SMN for some tissues.
Chang, H. C. et al. Modeling spinal muscular atrophy in Drosophila. PLoS ONE 3, e3209 (2008).
DiDonato, C. J. et al. Regulation of murine survival motor neuron (SMN) protein levels by modifying SMN exon 7 splicing. Hum. Mol. Genet. 10, 2727–2736 (2001).
Butchbach, M. E., Edwards, J. D. & Burghes, A. H. Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy. Neurobiol. Dis. 27, 207–219 (2007).
Carrel, T. L. et al. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 26, 11014–11022 (2006).
Fan, L. & Simard, L. R. Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum. Mol. Genet. 11, 1605–1614 (2002).
Wan, L. et al. The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol. Cell. Biol. 25, 5543–5551 (2005).
Gabanella, F., Carissimi, C., Usiello, A. & Pellizzoni, L. The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation. Hum. Mol. Genet. 14, 3629–3642 (2005).
Grimmler, M. et al. Phosphorylation regulates the activity of the SMN complex during assembly of spliceosomal U snRNPs. EMBO Rep. 6, 70–76 (2005).
Winkler, C. et al. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev. 19, 2320–2330 (2005).
McWhorter, M. L., Boon, K. L., Horan, E. S., Burghes, A. H. & Beattie, C. E. The SMN binding protein Gemin2 is not involved in motor axon outgrowth. Dev. Neurobiol. 68, 182–194 (2008).
Sheth, N. et al. Comprehensive splice-site analysis using comparative genomics. Nucleic Acids Res. 34, 3955–3967 (2006).
Alioto, T. S. U12DB: a database of orthologous U12-type spliceosomal introns. Nucleic Acids Res. 35, D110–D115 (2007).
Lee, S. et al. Genome-wide expression analysis of a spinal muscular atrophy model: towards discovery of new drug targets. PLoS ONE 3, e1404 (2008).
Olaso, R. et al. Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN. Physiol. Genomics 24, 97–104 (2006).
Corti, S. et al. Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J. Clin. Invest. 118, 3316–3330 (2008).
Schauber, J. et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117, 803–811 (2007).
Ule, J. et al. An RNA map predicting Nova-dependent splicing regulation. Nature 444, 580–586 (2006).
Wang, E. T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008).
Briese, M., Richter, D. U., Sattelle, D. B. & Ulfig, N. SMN, the product of the spinal muscular atrophy-determining gene, is expressed widely but selectively in the developing human forebrain. J. Comp. Neurol. 497, 808–816 (2006).
Jablonka, S., Beck, M., Lechner, B. D., Mayer, C. & Sendtner, M. Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy. J. Cell Biol. 179, 139–149 (2007).
Nishimune, H., Sanes, J. R. & Carlson, S. S. A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 432, 580–587 (2004).
Noakes, P. G., Gautam, M., Mudd, J., Sanes, J. R. & Merlie, J. P. Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin/laminin β2. Nature 374, 258–262 (1995).
Kariya, S. et al. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17, 2552–2569 (2008).
Narver, H. L. et al. Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Ann. Neurol. 64, 465–470 (2008).
Kong, L. et al. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 29, 842–851 (2009). A physiological characterization of NMJs in mice with intermediate SMA.
Dubowitz, V. & Sewry, C. A. Muscle Biopsy: A Practical Approach Vol. xiii (Saunders/Elsevier, 2007).
Wuhl, E. et al. Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am. J. Med. Genet. A 143, 311–319 (2007).
Swoboda, K. J. et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann. Neurol. 57, 704–712 (2005).
Glenney, J. R. Jr, Kaulfus, P., Matsudaira, P. & Weber, K. F-actin binding and bundling properties of fimbrin, a major cytoskeletal protein of microvillus core filaments. J. Biol. Chem. 256, 9283–9288 (1981).
Bretscher, A. Fimbrin is a cytoskeletal protein that crosslinks F-actin in vitro. Proc. Natl Acad. Sci. USA 78, 6849–6853 (1981).
Oprea, G. E. et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320, 524–527 (2008).
Cobben, J. M. et al. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am. J. Hum. Genet. 57, 805–808 (1995).
Jedrzejowska, M. et al. Unaffected patients with a homozygous absence of the SMN1 gene. Eur. J. Hum. Genet. 16, 930–934 (2008).
Faure, C. et al. Mechanical signals modulated vascular endothelial growth factor-A (VEGF-A) alternative splicing in osteoblastic cells through actin polymerisation. Bone 42, 1092–1101 (2008).
Murray, L. M. et al. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17, 949–962 (2008).
Coërs, C. & Woolf, A. L. The Innervation of Muscle; A Biopsy Study Vol. xv (Thomas, Springfield, 1959).
Yu, B. & Howell, P. L. Intragenic complementation and the structure and function of argininosuccinate lyase. Cell. Mol. Life Sci. 57, 1637–1651 (2000).
Rodriguez-Pombo, P. et al. Towards a model to explain the intragenic complementation in the heteromultimeric protein propionyl-CoA carboxylase. Biochim. Biophys. Acta 1740, 489–498 (2005).
Gonsalvez, G. B., Praveen, K., Hicks, A. J., Tian, L. & Matera, A. G. Sm protein methylation is dispensable for snRNP assembly in Drosophila melanogaster. RNA 14, 878–887 (2008).
Gonsalvez, G. B. et al. Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins. J. Cell Biol. 178, 733–740 (2007).
Nguyen thi, M. et al. A two-site ELISA can quantify upregulation of SMN protein by drugs for spinal muscular atrophy. Neurology 71, 1757–1763 (2008).
Young, P. J. et al. The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding. Hum. Mol. Genet. 9, 2869–2877 (2000).
Giesemann, T. et al. A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with SMN in nuclear gems. J. Biol. Chem. 274, 37908–37914 (1999).
Talbot, K. et al. Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? Hum. Mol. Genet. 6, 497–500 (1997).
Butchbach, M. E. R. & Burghes, A. H. M. Perspectives on models of spinal muscular atrophy for drug discovery. Drug Discov. Today Dis. Models 1, 151–156 (2004).
Prior, T. W. Spinal muscular atrophy diagnostics. J. Child. Neurol. 22, 952–956 (2007).
Zapletalova, E. et al. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy. Neuromuscul. Disord. 17, 476–481 (2007).
Rochette, C. F. et al. Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7. Neurogenetics 1, 141–147 (1997).
Hahnen, E. et al. Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). Hum. Mol. Genet. 6, 821–825 (1997).
Wang, C. H., Papendick, B. D., Bruinsma, P. & Day, J. K. Identification of a novel missense mutation of the SMN(T) gene in two siblings with spinal muscular atrophy. Neurogenetics 1, 273–276 (1998).
Burt, E. C., Towers, P. R. & Sattelle, D. B. Caenorhabditis elegans in the study of SMN-interacting proteins: a role for SMI-1, an orthologue of human Gemin2 and the identification of novel components of the SMN complex. Invert. Neurosci. 6, 145–159 (2006).
Rajendra, T. K. et al. A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle. J. Cell Biol. 176, 831–841 (2007).
Acknowledgements
We would like to thank all members of the SMA community for many helpful discussions. Owing to limited space we have not quoted all literature in the field, and we apologize to those whose articles are not referenced. We would like to thank L. Pellizzoni for many helpful comments on the manuscript and M. Butchbach for figure 2. We would like to thank all members of our laboratories for many useful discussions, in particular V. McGovern, who has read and edited many portions of this article in various formats. The work in our laboratories has been supported by the US National Institute of Neurological Disorders and Stroke, Families of SMA, Fight SMA, the SMA Foundation, the Madison, Matthew, Preston and Cade & Katelyn funds and the SMA Angels.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary information S1 (box)
Disruption of RNA metabolism in Neurological Disorders (PDF 264 kb)
Supplementary information S2 (box)
SMN and SnRNP assembly (PDF 198 kb)
Related links
Glossary
- Splicing
-
The removal of introns from pre-mRNA to obtain mRNA.
- Missense mutation
-
A mutation that results in the substitution of an amino acid in a protein.
- U small nuclear RNA
-
(U snRNA). A small nuclear RNA that is rich in uridine.
- Sm proteins
-
Proteins that were first found as antigens in a patient with systemic lupus erythematosus, and were named after the patient. Sm and Sm-like (LSm) proteins constitute a group of RNA-binding proteins that have a common three-dimensional stucture and form a heptameric or hexameric ring.
- Complementation
-
The ability of two mutant alleles to interact to produce a normal or milder phenotype. In general, this occurs when the mutations that give rise to the phenotype occur in two different genes. However, allelic complementation arises when different mutations in the same gene interact to produce a functional complex.
- Tudor domain
-
A conserved stretch of 50 amino acids, originally found in the Tudor protein of Drosophila melanogaster, that is often found in proteins with known roles in RNA metabolism.
- RNA granules
-
Cytoplasmic deposits that contain RNA. These can also be found in axons and dendrites. RNA in these granules may be transported to the distal axon for localized protein translation in the growth cone.
- Autosomal recessive disorder
-
A disorder that requires both copies of a gene on an autosomal (non-sex) chromosome to be mutated.
- Active zone
-
A portion of the presynaptic membrane that faces the postsynaptic density across the synaptic cleft. It constitutes the site of synaptic vesicle clustering, docking and neurotransmitter release.
- Informational suppressor
-
A suppressor that will modify a phenotype in a non-gene-specific manner. For example, overexpression of plastin 3 may encourage axon growth, thereby rescuing the phenotypes caused by SMN deficiency and those caused by mutations in other genes.
Rights and permissions
About this article
Cite this article
Burghes, A., Beattie, C. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?. Nat Rev Neurosci 10, 597–609 (2009). https://doi.org/10.1038/nrn2670
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrn2670